Genexine Inc (095700) — Capital Reinvestment Ratio

Latest as of March 2025: 4.87x

Genexine Inc (095700) has a Capital Reinvestment Ratio of 4.87x as of March 2025, meaning it reinvests 5% of its operating cash flow (₩799.82 Million) in capital expenditures (₩3.89 Billion). Check 095700 intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

4.87x
Capex / Operating Cash Flow

Operating Cash Flow

₩799.82 Million
KRW

Capital Expenditures

₩3.89 Billion
KRW

Data as of

Mar 2025
Most recent filing

Genexine Inc Capital Reinvestment Ratio (2009–2012)

This chart tracks Genexine Inc's Capital Reinvestment Ratio across 2 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Genexine Inc.

Annual Capital Reinvestment Ratio for Genexine Inc (2009–2012)

Year-by-year Capital Reinvestment Ratio for Genexine Inc from 2009 to 2012. See 095700 free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.

Year Reinvestment Ratio Operating CF (KRW) Capital Expenditures YoY Change
2012 1.45x ₩1.67 Billion ₩2.42 Billion ▼ -95.0%
2009 29.24x ₩35.23 Million ₩1.03 Billion
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow